[HTML][HTML] Mechanisms of resistance in castration-resistant prostate cancer (CRPC)

T Chandrasekar, JC Yang, AC Gao… - … andrology and urology, 2015 - ncbi.nlm.nih.gov
Despite advances in prostate cancer diagnosis and management, morbidity from prostate
cancer remains high. Approximately 20% of men present with advanced or metastatic …

Androgen receptor: structure, role in prostate cancer and drug discovery

MH Tan, J Li, HE Xu, K Melcher, E Yong - Acta Pharmacologica Sinica, 2015 - nature.com
Androgens and androgen receptors (AR) play a pivotal role in expression of the male
phenotype. Several diseases, such as androgen insensitivity syndrome (AIS) and prostate …

A hydrophobic ratchet entrenches molecular complexes

GKA Hochberg, Y Liu, EG Marklund, BPH Metzger… - Nature, 2020 - nature.com
Most proteins assemble into multisubunit complexes. The persistence of these complexes
across evolutionary time is usually explained as the result of natural selection for functional …

Boron in drug discovery: carboranes as unique pharmacophores in biologically active compounds

F Issa, M Kassiou, LM Rendina - Chemical reviews, 2011 - ACS Publications
Boron, in the form of boric acid, has played a role in medicine as a mild antiseptic and an
eye wash since its preparation from borax in the 18th century. However, the use of boron in …

The development of androgen-independent prostate cancer

BJ Feldman, D Feldman - Nature Reviews Cancer, 2001 - nature.com
The normal prostate and early-stage prostate cancers depend on androgens for growth and
survival, and androgen ablation therapy causes them to regress. Cancers that are not cured …

Molecular determinants of resistance to antiandrogen therapy

CD Chen, DS Welsbie, C Tran, SH Baek, R Chen… - Nature medicine, 2004 - nature.com
Using microarray-based profiling of isogenic prostate cancer xenograft models, we found
that a modest increase in androgen receptor mRNA was the only change consistently …

Androgen receptors in hormone-dependent and castration-resistant prostate cancer

AA Shafi, AE Yen, NL Weigel - Pharmacology & therapeutics, 2013 - Elsevier
Abstract In the United States, prostate cancer (PCa) is the most commonly diagnosed non-
cutaneous cancer in males and the second leading cause of cancer-related death for men …

Molecular biology of the androgen receptor

EP Gelmann - Journal of clinical oncology, 2002 - ascopubs.org
Androgen receptor (AR) is a member of the steroid hormone receptor family of molecules.
AR primarily is responsible for mediating the physiologic effects of androgens by binding to …

Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis

X Yuan, C Cai, S Chen, Z Yu, SP Balk - Oncogene, 2014 - nature.com
The metabolic functions of androgen receptor (AR) in normal prostate are circumvented in
prostate cancer (PCa) to drive tumor growth, and the AR also can acquire new growth …

Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds

S Kitamura, T Suzuki, S Sanoh, R Kohta… - Toxicological …, 2005 - academic.oup.com
The endocrine-disrupting activities of bisphenol A (BPA) and 19 related compounds were
comparatively examined by means of different in vitro and in vivo reporter assays. BPA and …